ClearPoint Neuro (CLPT) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CLPT Stock Alerts $5.31 -0.01 (-0.19%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic Systemfinance.yahoo.com - April 24 at 5:25 PMClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024finance.yahoo.com - April 23 at 8:09 PMClearPoint Neuro Poised for Growth: Strong Buy Rating Justified Amidst Market Dipmarkets.businessinsider.com - April 22 at 7:54 PMClearPoint Neuro (NASDAQ:CLPT) vs. United American Healthcare (OTCMKTS:UAHC) Critical Analysisamericanbankingnews.com - April 21 at 1:44 AMIs There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?finance.yahoo.com - April 19 at 10:22 AMClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutationsglobenewswire.com - April 16 at 4:05 PMClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Updatemarketbeat.com - April 15 at 11:13 PMThe 3 Most Promising MedTech Stocks to Invest In Nowinvestorplace.com - April 11 at 2:55 PMClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiencyglobenewswire.com - March 19 at 8:07 AMClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2023 Earnings Call Transcriptmsn.com - March 16 at 7:19 PMClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Yearfinance.yahoo.com - March 15 at 8:25 AMClearPoint Neuro Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 14 at 10:14 AMClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023finance.yahoo.com - March 12 at 9:17 PMClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Resultsglobenewswire.com - March 12 at 4:05 PMClearPoint Neuro is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - March 11 at 2:56 PMEarnings Outlook For ClearPoint Neurobenzinga.com - March 11 at 2:56 PMJournal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy Systemfinance.yahoo.com - March 11 at 9:55 AMThe Top 7 Under-$15 Stocks to Buy in March 2024investorplace.com - March 7 at 7:16 AMClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024finance.yahoo.com - March 1 at 5:41 PMClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024globenewswire.com - March 1 at 4:05 PMClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stockmarkets.businessinsider.com - February 29 at 4:23 PMClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stockglobenewswire.com - February 29 at 8:00 AMClearPoint Neuro Launches Proposed Public Offering of Common Stockglobenewswire.com - February 28 at 4:45 PMClearPoint Neuro’s Strategic Growth and Regulatory Milestones Bolster Buy Ratingmarkets.businessinsider.com - February 22 at 6:18 AMClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Modelfinance.yahoo.com - February 21 at 5:41 PMClearPoint Neuro, Inc.'s (NASDAQ:CLPT) largest shareholders are retail investors with 60% ownership, institutions own 32%finance.yahoo.com - February 18 at 10:37 AMClearPoint Neuro, Inc. (CLPT)finance.yahoo.com - February 16 at 9:05 PMThe 3 Up-and-Coming Stocks That Could Make Your February Unforgettableinvestorplace.com - February 15 at 4:19 PMThe Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn't Ignore.investorplace.com - February 15 at 1:00 PMClearPoint's (CLPT) Neuro Systems to Boost Neurosurgeriesmsn.com - January 30 at 3:23 PMClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalofinance.yahoo.com - January 24 at 8:58 PMClearPoint Neuro Gets EU OK For 2 Devicesmarketwatch.com - January 23 at 7:55 PMClearPoint Neuro receives EU okay for devices, Calif. plantmsn.com - January 22 at 5:53 PMClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europefinance.yahoo.com - January 22 at 5:53 PMClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR Systemmsn.com - January 17 at 4:11 PMClearPoint Neuro gets FDA clearance for SmartFrame ORmsn.com - January 16 at 7:13 PMClearPoint Neuro Announces FDA Clearance For SmartFrame OR Stereotactic Systemmarkets.businessinsider.com - January 16 at 9:12 AMClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic Systemfinance.yahoo.com - January 16 at 9:12 AMClearPoint Neuro, Inc.: ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenuefinanznachrichten.de - January 9 at 7:20 PMCyclacel Pharmaceuticals, ClearPoint Neuro among healthcare moversmsn.com - January 9 at 2:20 PMClearPoint Neuro reports prelim Q4 & FY rev of $6.8M and $24M, higher than consensusmsn.com - January 8 at 7:22 PMClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenuefinance.yahoo.com - January 8 at 7:22 PMClearPoint Neuro Inc's Innovative Pipeline Products Under Analysis in New 2023 Updatefinance.yahoo.com - December 28 at 10:18 AMThose who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%finance.yahoo.com - December 19 at 9:55 AMHow Much Upside is Left in ClearPoint Neuro, Inc. (CLPT)? Wall Street Analysts Think 48.77%msn.com - December 6 at 11:54 AMBuy Rating for ClearPoint Neuro Highlighting Precision MRI Guidance and Growth Potentialmarkets.businessinsider.com - December 2 at 7:25 AMAnalysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX) and ClearPoint Neuro (CLPT)markets.businessinsider.com - November 29 at 12:38 AMAre Investors Undervaluing ClearPoint Neuro, Inc. (NASDAQ:CLPT) By 41%?finance.yahoo.com - November 22 at 10:06 AMClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcriptinsidermonkey.com - November 10 at 3:04 PMClearPoint Neuro Reports Third Quarter 2023 Resultsfinance.yahoo.com - November 9 at 8:15 PM Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide CLPT Media Mentions By Week CLPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLPT News Sentiment▼0.530.36▲Average Medical News Sentiment CLPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLPT Articles This Week▼51▲CLPT Articles Average Week Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Quipt Home Medical News Today Orchestra BioMed News Today TELA Bio News Today Neuronetics News Today Delcath Systems News Today Allurion Technologies News Today Alpha Tau Medical News Today Profound Medical News Today KORU Medical Systems News Today BlueRiver Acquisition News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLPT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
